Skip to content
Dose Brief
Menu
No. 175 here · Grade C

Claya review

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Visit Claya Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $299/mo (compounded)
Tirzepatide
From $299/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from Claya's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026. The published line reads From $299/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Claya scored on our six Brief Score factors. See the methodology.

Price Stability58/100
Supply Reliability75/100
Transparency72/100
Access Breadth56/100
Clinical Oversight82/100
Track Record73/100

What we like

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

The caveats

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

The brief

Best for: Readers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Ranked #175 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Claya.

Closest here

The providers scoring nearest Claya — the realistic shortlist if you're weighing it.

Weighing Claya against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Claya, and every provider that outranks it is listed on the Claya alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Claya's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.

← Back to all rankings